mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
marinopyrrole A |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.2 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
NSC-87877 |
GDSC1000 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.2 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
Bosutinib |
GDSC1000 |
pan-cancer |
AAC |
0.045 |
0.2 |